United Kingdom · Question · Written question
UIN 137222
Coronavirus: Ivermectin
Introduced
9 March 2022
Last action
8 April 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
8 April 2022
Summary
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 December to Question 88624 and the Answer of 28 February 2022 to Question 127264 on Coronavirus: Ivermectin2, what the decision making process was for the Ivermectin be
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
9 March 2022
Written question
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 20 December to Question 88624 and the Answer of 28 February 2022 to Question 127264 on Coronavirus: Ivermectin2, what the decision making process was for the Ivermectin be
Source: Commons
8 April 2022
Answer
Ivermectin has been a controversial drug throughout the pandemic, with many clinicians prescribing globally with no clear evidence to demonstrate there is a benefit. Taking this into consideration and the need to generate evidence on ivermectin’s efficacy...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-03-09/137222
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1439197
- uk · wq-1439197 · source updated 8 April 2022